HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Volume 20, Volume 2, February 2016 Biomedical Research Governance       » Tissue banking in Singapore — An Evolving Enterprise       » China Recognizes Prominent Scientists and Stresses on Innovation       » NUS Researchers Uncover Potent Parasite-killing Mechanism of Nobel Prize-Winning Anti-Malarial Drug       » A New Water Robot "Born" to Detect Water Quality       » Probing the Mystery of How Cancer Cells Die       » Researchers Find Link between Processed Foods and Autoimmune Diseases       » Unravelling the Genetics of Pregnancy and Heart Failure      
BIOBOARD - SINGAPORE
A*STAR Researchers Create Novel Assay to Test for Epigenetic Abnormalities in Pre-implanted Mice Embryos

Scientists from A*STAR’s Institute of Medical Biology (IMB) and Institute of Molecular and Cell Biology (IMCB) have created a novel assay to probe the DNA methylation state of multiple genomic loci in single cells.

An embryo’s normal development requires certain epigenetic changes to take place during early development; one type of epigenetic change is called ‘DNA methylation’. This is a crucial process for an embryo’s early development because it selectively ‘switches off’ certain genes – helping its cells grow into different cell types.

Errors in this epigenetic process, such as ‘switching off’ the wrong genes, are known causes of early developmental diseases and cell death. Two of which are Beckwith-Wiedemann and Silver-Russell syndromes. Both syndromes are extreme examples of epigenetic diseases — Beckwith-Wiedemann syndrome causes rapid overgrowth in infants while Silver-Russell syndrome causes slow growth resulting in delayed development and learning disabilities in children.

An important first-step to address the debilitating effects of epigenetic diseases is to find a way to identify embryos with ‘troubled’ methylation states. The single cell methylation assay developed by the researchers from IMB and IMCB can be used to safely extract one cell for testing in an embryo fertilised in vitro. Previous similar assays required large numbers of cells for testing, which would destroy the embryo. The benefit of extracting one cell per assay is that the remaining cells of the embryo can be left to mature normally.

Unique Microfluidic Technique Secret to Discovery

Working hand-in-hand, scientists from IMB and IMCB were able to use a special technique using a microfluidic device to perform the assay with the small amounts of DNA present in a single cell. Microfluidics is the process of handling minute volumes of liquid. The Microfluidics Systems Biology Lab at IMCB includes an interdisciplinary team of engineers and biologists. According to Dr. William F. Burkholder, who co-directs the lab said, "It is having engineers and biologists working together and learning from each other that facilitates the development of cutting-edge tools for biomedical research."

Potential Screening and Treatment

The scientists also made another important discovery — they were able to return normal epigenetic functions back to a pre-implanted embryo suffering from improper epigenetic development. Researchers used a technique called ‘pronuclear transfer’ that takes the genome from a defective embryo and inserts it into a healthy embryo. Even though this technique had been performed successfully before, this is the first time scientists have shown an embryo with defective maternal epigenetic regulation can be rescued using the technique.

The success of pronuclear transfer and the single cell assay raises the possibility that therapeutic treatments in the field of Assisted Reproductive Technology (ART) can be developed to correct maternally-inherited epigenetic disease syndromes. The lead researcher on this study, Dr. Daniel M. Messerschmidt said, “It becomes increasingly evident that epigenetic defects which predominantly develop at the very early stages of pregnancy cause infertility, abortion or complex syndromes. Studies like ours, in which new powerful methods are developed to uncover the detailed molecular principles involved, create the basis for future clinical research, and eventually, clinical applications”.

Click here for the complete issue.

NEWS CRUNCH  
news EmTech Asia Opens: Features 50 speakers on innovation and emerging technologies
news Russia's only project to supply local high-tech anti-cancer drugs abroad continues with the first shipment to Vietnam
news Wheat Genome Sequencing Gets Major Boost
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Primates in Biomedical Research
COLUMNS  
\
APBN Editorial Calendar 2016
January:
Guest Editorial - Biotechnology In Korea
February:
Guest Editorial - Biomedical Research Governance
March:
Guest Editorial - Life-Saving Opportunities: A Guide to Regenerative Medicine
April:
Cancerology / Oncology
May:
Guest Editorial - Antibody Informatics In Japan
June:
Medical Devices and Technology
July:
Water Technology
August:
Occupational Health
September:
Olympics: Evolution of Sports
October:
Respiratory: Seasonal flu viruses
November:
Tobacco Smoking
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim/td>
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy